Delivery Order SPE2DR25D6029-SPE2DR26FXQ0C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Amitriptyline HCL 25 mg tablets (1,000 count) valued at $1,567.08. This competitively awarded, firm fixed-price delivery order is not set aside and is scheduled for completion by July 24, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of 1,000 units of Amitriptyline 25mg, a tricyclic antidepressant medication commonly used for pain management and neurological conditions. This firm fixed-price delivery order, valued at $1,025.44, is set to be completed by November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,705.32 for 1,000 tablets of Amitriptyline HCl 10 mg, with an ultimate completion date of September 17, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $4,163.10 to AmerisourceBergen Drug Corp for the supply of Amitriptyline HCL 75 mg tablets (100-count bottles) under a firm fixed price contract type. This award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive delivery order with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amitriptyline HCL 10 mg tablets (1,000 count) under a firm fixed-price contract with a ceiling value of $3,954.35. The order, awarded on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a $1,231.01 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for 1,000 tablets of Amitriptyline HCL 25 mg, with completion targeted for July 11, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 units of Amitriptyline 25mg tablets on June 27, 2025. This firm fixed-price delivery order, valued at $1,538.13, represents a single transaction under a larger contract vehicle and was competitively awarded without set-aside provisions. The pharmaceutical product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with a completion date of June...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at three hundred eighty-nine dollars and ten cents ($389.10) to Amerisourcebergen Drug Corporation for one hundred (100) tablets of 50mg amitriptyline hydrochloride. Performance will occur at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a one-day period concluding on July 26, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a...
- The Defense Logistics Agency awarded a delivery order valued at $1,595.68 to AmerisourceBergen Drug Corp for 1,000 tablets of Amitriptyline HCL 25 mg, with an ultimate completion date of August 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Amitriptyline is a tricyclic antidepressant commonly used in military and veteran healthcare systems for mood disorders...
- The Defense Logistics Agency awarded a delivery order under an undisclosed contract vehicle to Amerisourcebergen Drug Corporation for 1,000 tablets of 10mg amitriptyline hydrochloride. Valued at $329.79, this firm fixed price order will be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by August 25, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the antidepressant medication supports the Defense Logistics...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXQ0CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of 1,000 tablets of Amitriptyline HCL 10 mg, a generic antidepressant medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,380.79, represents a non-competitive set-aside award and is scheduled for completion by November 10, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices to support military and federal healthcare programs globally. The company's selection reflects its established capability to meet federal procurement standards through competitive processes and its critical role in supporting the Defense Health Agency and other government healthcare systems with essential pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/7/25 |